CCM
MRK icon

Callodine Capital Management’s Merck MRK Stock Holding History

Callodine Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-175,652
Closed -$15.1M – 46
2022
Q3 		$15.1M Buy
175,652
+20,652
+13% +$1.84M 4.71% 5
2022
Q2 		$14.1M Buy
155,000
+140,000
+933% +$12.4M 4.19% 4
2022
Q1 		$1.23M Buy
+15,000
New +$1.18M 0.4% 40

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Callodine Capital Management's MRK Position: Q4 2022 in Review

Callodine Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 175,652 shares — an estimated $15.1M sold.

Callodine Capital Management first reported a position in MRK in Q1 2022 and held it in 3 quarters. The position peaked at $15.1M in Q3 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Callodine Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Callodine Capital Management sold 175,652 Merck shares in Q4 2022, an estimated $15.1M.
  • Callodine Capital Management first reported a position in Merck in Q1 2022 and held it in 3 quarters.
  • Callodine Capital Management's Merck position peaked at $15.1M in Q3 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Callodine Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.